Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus
Autor: | Satoshi Matsutani, Hiroyuki Konya, Masayuki Miuchi, Tomoyuki Katsuno, Mitsuyoshi Namba, Kahori Satani, Taku Tsunoda, Jun-ichiro Miyagawa, Tomoya Hamaguchi, Yuzo Yano |
---|---|
Rok vydání: | 2014 |
Předmět: |
Carotid atherosclerosis
medicine.medical_specialty Cerebral infarction business.industry Endocrinology Diabetes and Metabolism Review Serum concentration medicine.disease Endocrinology Internal medicine Diabetes mellitus Internal Medicine medicine Biomarker (medicine) Hepatocyte growth factor Multivariate statistical Artery diseases business medicine.drug |
Zdroj: | World Journal of Diabetes. 5:678 |
ISSN: | 1948-9358 |
DOI: | 10.4239/wjd.v5.i5.678 |
Popis: | Atherosclerotic involvements are an essential causal element of prospect in diabetes mellitus (DM), with carotid atherosclerosis (CA) being a common risk-factor for prospective crisis of coronary artery diseases (CAD) and/or cerebral infarction (CI) in DM subjects. From another point of view, several reports have supplied augmenting proof that hepatocyte growth factor (HGF) has a physiopathological part in DM involvements. HGF has been a mesenchymal-derived polyphenic factor which modulates development, motion, and morphosis of diverse cells, and has been regarded as a humor intermediator of epithelial-mesenchymal interplays. The serum concentrations of HGF have been elevated in subjects with CAD and CI, especially during the acute phase of both disturbances. In our study with 89 type 2 DM patients, the association between serum concentrations of HGF and risk-factors for macrovascular complications inclusive of CA were examined. The average of serum HGF levels in the subjects was more elevated than the reference interval. The serum HGF concentrations associated positively with both intimal-media thickness (IMT) (r = 0.24, P = 0.0248) and plaque score (r = 0.27, P = 0.0126), indicating a relationship between the elevated HGF concentrations and advancement of CA involvements. Multivariate statistical analysis accentuated that serum concentrations of HGF would be associated independently with IMT (standardized = 0.28, P = 0.0499). The review indicates what is presently known regarding serum HGF might be a new and meaningful biomarker of macroangiopathy in DM subjects. |
Databáze: | OpenAIRE |
Externí odkaz: |